Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Pesquisa Nacional de Saúde revela alto percentual de sinais e sintomas de hanseníase no Brasil

Penna GO, Pontes MADA, Nobre ML, et al. FapUNIFESP (SciELO). Ciência & Saúde Coletiva. 2022; 27 (6) : 2255-2258.
Download PDF
Publication

Time-to-Disability Determinants Among Leprosy Patients Enrolled for Treatment at ALERT Center, Addis Ababa, Ethiopia: A Survival Analysis

Masresha BM, Biresaw HB, Moyehodie YA, et al. Informa UK Limited. Infection and Drug Resistance. 2022;
Download PDF
Publication

RehApp Mobile app - Rehabilitation Knowledge Base for fieldworkers

Enablement. 2022;
Download PDF
Publication

Aspectos sobre a patogênese, a clínica, o diagnóstico e o tratamento da hanseníase: uma revisão narrativa

Da Silva Vieira SM, Silva de Lima LF, Alves Soares Vaz de Castro PASVDC, et al. Journal of Education, Science and Health - JESH. Journal of Education Science and Health. 2022; 2 (2) : 1-11.
Download PDF
Publication

Painful bullae in a febrile woman: a clue to first presentation of multibacillary Hansen's disease.

Laishram R, Sophia M, Hazarika N. BMJ case reports. 2022;
Download PDF
Publication

Ulnar Artery Perforator Adiposal Flap for Paraffinoma Treatment in a Patient With Leprosy: A Case Report.

Morimoto Y, Sogabe Y, Kawabata A, et al. Journal of hand surgery global online. 2022; 4 (3) : 172-175.
Download PDF
Publication

Necrotizing Soft Tissue Infection of the Upper Extremity as a Manifestation of Hansen's Disease.

Bougioukli S, Williams E, Nwachuku I, et al. Journal of hand surgery global online. 2022; 4 (3) : 176-180.
Download PDF
Publication

A single dose of rifampicin to prevent leprosy: qualitative analysis of perceptions of persons affected, contacts, community members and health professionals towards chemoprophylaxis and the impact on their attitudes in India, Nepal and Indonesia

Peters R, Mieras L, Subedi M, et al. Lepra. Leprosy Review. 2018; 89 (4) : 335-352.
Download PDF
Publication

Clinicopathological Profile of Cases Attending Leprosy Clinic in a Tertiary Care Hospital of South Tamil Nadu and Its Correlation with Current Leprosy Trends under NLEP

Nirmaladevi P, Arunkumar B, Judith Joy J, et al. Indian Journal of Leprosy. 2021;
Download PDF
Publication

Study of Red Blood Cell Distribution Width (RDW) as Hematological Inflammatory Marker in Leprosy and Lepra Reactions

Ambalia DG, Vaishnani J, Desai VA. Indian Journal of Leprosy. 2021;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 207
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD